Compound ID | 231

Update compound information

Pyridodiazepine amine compound A

Class: MurI inhibitor

Spectrum of activity: Gram-negative
Details of activity: This study showed the HTS hit to be a selective inhibitor for H. pylori, and the suppression of growth was confirmed to be mediated by the inhibition of MurI. NOT WARRANTED FOR CLINICAL DEVELOPMENT, NOT HIGH ENOUGH POTENCY.
Description: Pyridodiazepine amine
Institute where first reported: AstraZeneca - UK
Year first mentioned: 2014
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 322.39
Iso. SMILES: CN=C1C(N=C(C2=C(N1)N=CC=C2)C3=CC=CO3)C4=CC=CS4
InChI Key: DPMRHTYMAOIWBU-UHFFFAOYSA-N
Can. SMILES: CN=C1C(C2=CC=CS2)N=C(C3=CC=CN=C3N1)C4=CC=CO4
InChI: InChI=1S/C17H14N4OS/c1-18-17-15(13-7-4-10-23-13)20-14(12-6-3-9-22-12)11-5-2-8-19-16(11)21-17/h2-10,15H,1H3,(H,18,19,21)
External links:
Structure link: https://pubchem.ncbi.nlm.nih.gov/compound/135423770
Citations:
  • http://aac.asm.org/content/58/10/6165.full
  • http://aac.asm.org/content/59/4/2337.full
  • https://journals.asm.org/doi/full/10.1128/aac.04410-14

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.